The prognostic effect of dual <sup>68</sup>Ga -DOTANOC and <sup>18</sup>F -FDG PET/CT examination on patients with metastatic gastrointestinal neuroendocrine tumors undergoing surgical or medical treatment.

Modifying the treatment plan, implementing precise clinical intervention, prioritizing treatment, and regularly monitoring the patients will undoubtedly be highly significant in enhancing the prognosis. 243 eligible patients were included in the study, which provided a relatively sufficient sample size that increased the statistical power of the analyses.

also in 132,142 other papers